2 results match your criteria: "Leduc Farm Animal Hospital[Affiliation]"
Theriogenology
February 2025
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos, Aires, 1425, Argentina; Instituto de Investigaciones en Reproducción Animal (INIRA), Facultad de Ciencias Veterinarias, Universidad Nacional de la Plata, La Plata, B1900, Buenos Aires, Argentina.
This study compared the effect of a 7-day estradiol- and a 7-day GnRH-based FTAI protocol versus a presynchronized GnRH-based FTAI protocol (7 & 7 GnRH) on pregnancy per AI (P/AI) in multiparous postpartum Angus cows. Cows were blocked according to presence/absence of a CL, body condition score, and days postpartum and assigned randomly to one of three treatments: I) 7-day EB (n = 368), estradiol benzoate (EB) and intravaginal progesterone-(P4)-releasing device (IVPD) on Day -10, prostaglandin F (PG), equine chorionic gonadotropin (eCG) and estradiol cypionate (ECP) at IVPD removal on Day -3 with FTAI done on Day -1 (54 ± 2 h after IVPD removal); II) 7-day GnRH (n = 367), GnRH at IVPD insertion on Day -10, PG and eCG at IVPD removal on Day -3 with GnRH and FTAI on Day 0 (66 ± 2 h after IVPD removal); and III) 7 & 7 GnRH (n = 361), PG at IVPD insertion on Day -17, GnRH on Day -10, IVPD removal, PG and eCG on Day -3 with GnRH and FTAI on Day 0 (66 ± 2 h after IVPD removal). Preovulatory follicle diameter, corpus luteum (CL) presence, CL area, and P4 concentration were determined at IVPD removal, as well as estrus expression at FTAI and P/AI between 35 and 40 days after FTAI.
View Article and Find Full Text PDFReprod Domest Anim
August 2024
Leduc Farm Animal Hospital, Leduc, Canada.
This study compared reproductive outcomes among two protocols for synchronization of ovulation that provide for a lengthened proestrus with the conventional oestradiol-based protocol currently used for timed-AI (TAI). Holstein heifers (13-15 months) at one location were assigned randomly to one of three TAI protocols. Heifers (n = 150) in the 7-day oestradiol benzoate (EB) group received a progesterone device (Cue-Mate) and 2 mg EB on Day 0; 500 μg of cloprostenol (PGF) and Cue-Mate removal on Day 7; 1 mg of EB on Day 8 and TAI on Day 9 (54 h after Cue-Mate removal).
View Article and Find Full Text PDF